Katherine Stueland, GeneDx CEO, joins 'Closing Bell' to discuss company earnings and the future of genome sequencing.

Whole genome sequencing can be an exceptionally valuable tool in cancer diagnostics. The application of this technique can ...

The costs of genomic sequencing have fallen very rapidly for the past decade and will continue to do so. As it becomes less ...

The provision will enable whole genome sequencing for neonatal and paediatric patients in intensive care units within 48 ...

The DNA Sequencing Industry has rapidly transformed into one of the most crucial areas of biotechnology. What was once a time ...

A Texas-based lab is used by law enforcement in cases where local and state labs have failed to extract DNA from degraded or ...

As SARS-CoV-2 variants of concern emerged, the genome sequencing of SARS-CoV-2 strains became more important. In this study, SARS-CoV-2 was sequenced using amplicon-based genome sequencing with MinION ...

A research team has achieved a gapless assembly of Syntrichia caninervis's genome, totaling 323.44 Mbp with an N50 value of ...

In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled today its proprietary, breakthrough sequencing by expansion (SBX) technology, ...

Evo-2, a groundbreaking AI model, generates DNA sequences and aids in genome analysis, enhancing genetic research.